Jing Sun

10.1k total citations · 2 hit papers
120 papers, 8.1k citations indexed

About

Jing Sun is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jing Sun has authored 120 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Immunology, 38 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Jing Sun's work include Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (27 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Jing Sun is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (27 papers) and Cancer Immunotherapy and Biomarkers (19 papers). Jing Sun collaborates with scholars based in China, United States and Israel. Jing Sun's co-authors include Steven Μ. Albelda, Veena Kapoor, Guanjun Cheng, Zvi G. Fridlender, G. Scott Worthen, Samuel Kim, Leona Ling, Youhai H. Chen, Sunil Singhal and Brendan Hilliard and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jing Sun

119 papers receiving 8.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

2009 2.6k citations Zvi G. Fridlender, Jing Sun et al. profile →
A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors

2016 420 citations Xiaojun Liu, Raghuveer Ranganathan et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jing Sun China	41	5.0k	3.8k	2.1k	951	612	120	8.1k
Zvi G. Fridlender Israel	30	5.7k 1.1×	3.6k 1.0×	1.7k 0.8×	698 0.7×	642 1.0×	74	8.1k
Elaine Y. Lin United States	31	3.9k 0.8×	4.0k 1.1×	3.5k 1.7×	1.6k 1.7×	549 0.9×	41	8.5k
Fathia Mami‐Chouaib France	47	4.8k 1.0×	3.7k 1.0×	2.2k 1.0×	1.2k 1.3×	378 0.6×	107	7.9k
Seth B. Coffelt United Kingdom	34	4.6k 0.9×	3.6k 0.9×	2.7k 1.3×	1.3k 1.4×	535 0.9×	62	8.3k
Ferdy J. Lejeune Switzerland	44	3.2k 0.7×	3.3k 0.9×	2.6k 1.3×	566 0.6×	435 0.7×	119	7.3k
Yiwei Chu China	50	3.6k 0.7×	2.4k 0.6×	2.9k 1.4×	1.3k 1.4×	358 0.6×	182	7.7k
Srinivas Nagaraj United States	23	9.2k 1.9×	4.7k 1.3×	2.5k 1.2×	952 1.0×	514 0.8×	34	11.6k
Emina H. Huang United States	35	2.0k 0.4×	4.1k 1.1×	2.7k 1.3×	1.4k 1.5×	356 0.6×	110	7.3k
Zvi Granot Israel	33	2.8k 0.6×	1.9k 0.5×	1.9k 0.9×	533 0.6×	433 0.7×	58	5.5k
Luigi Laghi Italy	37	3.1k 0.6×	3.7k 1.0×	2.1k 1.0×	1.1k 1.2×	483 0.8×	103	7.0k

Countries citing papers authored by Jing Sun

Since Specialization

Citations

This map shows the geographic impact of Jing Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Sun more than expected).

Fields of papers citing papers by Jing Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Sun. The network helps show where Jing Sun may publish in the future.

Co-authorship network of co-authors of Jing Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Sun. A scholar is included among the top collaborators of Jing Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Sun. Jing Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Zhichao, Yajun Shi, Xiaofei Zhang, et al.. (2024). Research progress in the ethnopharmacology, phytochemistry, pharmacology, toxicology, and quality control of Valeriana jatamansi Jones. Journal of Ethnopharmacology. 332. 118403–118403. 3 indexed citations

Zhai, Bingtao, Dan Zhang, Jing Sun, et al.. (2024). Study on the underlying mechanism of Huachansu Capsule induced cardiotoxicity of normal rat by integrating transcriptomics, metabolomics and network toxicology. Journal of Ethnopharmacology. 336. 118751–118751. 5 indexed citations

Yang, Jie, Jian Xiong, Yawen Zhang, et al.. (2024). PD‐L2 Expression in Breast Cancer Promotes Tumor Development and Progression. Journal of Immunology Research. 2024(1). 3145695–3145695. 1 indexed citations

Li, Wengang, Qian Chen, Wei-Ping He, et al.. (2024). Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy. Frontiers in Immunology. 15. 1508028–1508028. 2 indexed citations

Sun, Jing, Wengang Li, Wei-Ping He, et al.. (2024). Radiofrequency Ablation Therapy versus Stereotactic Body Radiation Therapy for Naive Hepatocellular Carcinoma (≤5cm): A Retrospective Multi-Center Study. Journal of Hepatocellular Carcinoma. Volume 11. 2199–2210. 2 indexed citations

Yang, Jie, et al.. (2023). B7-H3 promotes angiogenesis in rheumatoid arthritis. Molecular Immunology. 165. 19–27. 3 indexed citations

Zhang, Yawen, Mengmeng Wang, Fanyi Meng, et al.. (2022). A novel SRSF3 inhibitor, SFI003, exerts anticancer activity against colorectal cancer by modulating the SRSF3/DHCR24/ROS axis. Cell Death Discovery. 8(1). 238–238. 17 indexed citations

Niu, Nan, et al.. (2020). IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1. FEBS Open Bio. 10(12). 2687–2701. 11 indexed citations

Kimura, Tōru, James Monslow, Astero Klampatsa, et al.. (2019). Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 317(2). L271–L282. 25 indexed citations

10.

Kiseleva, Raisa Y., Colin F. Greineder, Carlos H. Villa, et al.. (2017). Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1. PLoS ONE. 12(1). e0169537–e0169537. 11 indexed citations

11.

Liu, Xiaojun, Raghuveer Ranganathan, Shuguang Jiang, et al.. (2016). A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors. Cancer Research. 76(6). 1578–1590. 420 indexed citations breakdown →

12.

Newick, Kheng, Shaun O’Brien, Jing Sun, et al.. (2016). Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization. Cancer Immunology Research. 4(6). 541–551. 160 indexed citations

13.

Chen, Lei, Qiong Shen, Tong Liu, et al.. (2015). Characterization and clinical relevance of circulating CD4+CD28− T cells in Graves’ disease. Immunology Letters. 165(1). 47–51. 3 indexed citations

14.

Zhou, Huan, Weipeng Wang, Yong Mao, et al.. (2015). Expression of Oct-4 is significantly associated with the development and prognosis of colorectal cancer. Oncology Letters. 10(2). 691–696. 13 indexed citations

15.

Chen, Jie, Fengming Wang, Shuang Shen, et al.. (2013). A Novel Anti-human ICOSL Monoclonal Antibody that Enhances IgG Production of B Cells. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 32(2). 125–131. 5 indexed citations

16.

Yan, Ruhong, Shun Yang, Jing Sun, et al.. (2012). A Novel Monoclonal Antibody Against Mouse B7-H3 Developed in Rats. Hybridoma. 31(4). 267–271. 4 indexed citations

17.

Wang, Fengming, Tao Yan, Lujun Chen, et al.. (2012). Involvement of Inducible Costimulator Ligand (ICOSL) Expression in Thyroid Tissue in Hyperthyroidism of Graves’ Disease Patients. Journal of Clinical Immunology. 32(6). 1253–1261. 9 indexed citations

18.

Fridlender, Zvi G., George Buchlis, Veena Kapoor, et al.. (2009). CCL2 Blockade Augments Cancer Immunotherapy. Cancer Research. 70(1). 109–118. 151 indexed citations

19.

Kim, Samuel, George Buchlis, Zvi G. Fridlender, et al.. (2008). Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy. Cancer Research. 68(24). 10247–10256. 71 indexed citations

20.

Hilliard, Brendan, Nicola J. Mason, Lingyun Xu, et al.. (2002). Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. Journal of Clinical Investigation. 110(6). 843–850. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact